SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers
2 other identifiers
interventional
44,729
1 country
1
Brief Summary
SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, uptake, and long-term sustainability of COVID-19 screening and testing among Utah's Community Health Center patient population. The study will compare two practical, feasible, scalable interventions to increase COVID-19 testing uptake in Utah Community Health Centers:
- 1.Text Messaging (TM): population health management (PHM) intervention that analyzes EHR data to automatically identify patients with high risk for either infection or severe disease, reaches and screens those patients, and addresses testing logistics using bi-directional text messaging.
- 2.Patient Navigation (PN): PHM intervention to increase testing uptake among eligible patients (identified via TM) using patient navigation (e.g., motivating patients, addressing logistics and barriers).
- 3.Implement and evaluate PHM interventions for increasing the uptake of COVID-19 testing among CHC patients across Utah. Our primary outcome, Uptake-Eligible, is defined as the proportion of patients who are tested for COVID-19 out of the patients who meet screening criteria for COVID-19 testing. Our study hypothesis is that patients in the TM+PN cohort will have higher rates of uptake-eligible than those in the TM cohort.
- 4.Examine implementation effectiveness outcomes, as well as characteristics of both clinics and patients that may influence intervention effects and implementation outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Mar 2021
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2021
CompletedFirst Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
June 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedResults Posted
Study results publicly available
February 4, 2026
CompletedFebruary 4, 2026
December 1, 2025
1.2 years
April 7, 2021
August 25, 2023
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reach-TM Engage
Proportion of patients that respond to the Text Messaging intervention.
12 months
Secondary Outcomes (4)
Total Patients Tested for COVID as Indicated in Health Record Out of Total Patient Population in Study. (Uptake-Total)
12 months
Reach PN-Engage-Logistics Assistance
12 months
Reach PN-Engage-Requested Navigation
12 months
Uptake-Eligible
12 months
Study Arms (2)
Text-Messaging (TM)
ACTIVE COMPARATORPopulation health management intervention that analyzes electronic health record data to automatically identify participants with high risk for either infection or severe disease and proactivity reaches those participants via text message for testing needs (as advised by state and/or federal guidelines) and testing recommendation when applicable. This is a bi-directional text messaging system.
Text-Messaging plus Patient Navigation (TM+PN)
ACTIVE COMPARATORPopulation health management intervention that includes the same bi-directional text-messaging system as Arm 1 (the text messaging condition) with the addition of patient navigation. Patient navigation includes real-time assistance from a community health worker to address barriers, provide motivation, and assist with logistics of COIVD testing.
Interventions
Patients in the TM condition will receive HIPAA-compliant bidirectional text messages. Texts will include a brief message regarding COVID-19 risk and will screen the participants for COVID testing needs. Participants who reply "yes" to accepting testing will receive additional messages with a recommendation to be tested, testing locations/hours/phone, and an offer to receive a free at-home test mailed to their home. Patients who reply "no" will receive a text with the clinic phone number and a note to call if anything changes.
Patients in the PN condition, who respond "yes" to accepting testing will receive additional messages with a recommendation to be tested, testing locations/hours/phone, and an offer to receive a free at-home test mailed to their home. In addition they will receive a notice via text message that a Community Health Worker will contact them for patient navigation. At this time, patients will will have the option to opt-out of the phone call from the patient navigator. The Patient Navigation includes advice from navigators to address practical barriers to COVID testing such as logistics, transportation, and expenses as well as behavioral barriers such as hesitancy, fear, and uncertainty.
Eligibility Criteria
You may qualify if:
- current patient of a participating community health center
- own a working cellphone,
- have their phone number listed in their existing electronic medical record at a participating clinic,
- speak English or Spanish.
You may not qualify if:
- Minors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Association for Utah Community Healthcollaborator
- Utah Department of Healthcollaborator
- National Institutes of Health (NIH)collaborator
- National Center for Advancing Translational Sciences (NCATS)collaborator
Study Sites (1)
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The outcomes (Uptake-Eligible) and (Uptake-Total) require the collection of individualized COVID-19 testing data. As COVID testing options evolved throughout the pandemic, our ability to track eligibility and collect testing outcomes from all available sources greatly diminished. We have no individualized testing data and therefore are unable to analyze Uptake-Total and Uptake-Eligible outcomes.
Results Point of Contact
- Title
- David Wetter
- Organization
- Huntsman Cancer Institute at University of Utah
Study Officials
- PRINCIPAL INVESTIGATOR
David Wetter, MS, PhD
University of Utah
- PRINCIPAL INVESTIGATOR
Rachel Hess, MD, MS
University of Utah
- PRINCIPAL INVESTIGATOR
Guilherme Del Fiol, MD, PhD
University of Utah
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients will not know if they are in the TM or TM+PN intervention arm.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Center for Health Outcomes and Population Equity
Study Record Dates
First Submitted
April 7, 2021
First Posted
June 25, 2021
Study Start
March 29, 2021
Primary Completion
June 17, 2022
Study Completion
February 28, 2023
Last Updated
February 4, 2026
Results First Posted
February 4, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share